Antibiotics Aren’t Profitable Enough for Big Pharma to Make More

10 May 2019

Public health experts are calling for new incentives to reward companies for bringing drugs that are effective against resistant strains to market.

Further reading: Bloomberg

Back

OUR UNDERWRITERS

Unrestricted financial support by:

	LifeArc
	Antimicrobial Resistance Fighter Coalition
	Bangalore Bioinnovation Centre
	INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

Connect to over 550 AMR professionals and students in 60 countries!